Receive up-to-the-minute news updates on the hottest topics with NewsHub. Install now.

Sanofi invests 170 million euros in French vaccines facility

October 12, 2017 5:08 AM
46 0

PARIS (Reuters) - Sanofi will invest 170 million euros ($202 million) to expand its vaccines manufacturing site at Val-de-Reuil in north-western France, in a drive aimed at boosting the production of one of its influenza vaccines.

The French drugmaker said on Thursday that the new facility would allow its Sanofi Pasteur vaccines division to expand the supply of the VaxigripTetra product to up to 70 countries. Production at the new facility will start from 2022 onwards.

Also read: Health Insurer Shuns Amniotic-Tissue Product From MiMedx

Read more

Share in social networks:

Comments - 0